Aix Marseille Univ, INSERM, INRA, C2VN, Marseille, France.
Aix Marseille Univ, INSERM, INRA, C2VN, Marseille, France; CriBioM, Criblage Biologique Marseille, Faculté de Médecine de la Timone, Marseille, France.
J Steroid Biochem Mol Biol. 2019 Jan;185:39-46. doi: 10.1016/j.jsbmb.2018.07.006. Epub 2018 Jul 7.
Low circulating levels of total and free 25-hydroxyvitamin D (25(OH)D) indicative of vitamin D status have been associated with obesity in humans. Moreover, obesity is thought to play a causal role in the reduction of 25(OH)D levels, and several theories have been put forward to explain this relationship. Here we tested the hypothesis that obesity disrupts vitamin D homeostasis in key organs of vitamin D metabolism. Male C57BL6 mice were fed for 7 or 11 weeks on either a control diet (control, 10% energy from fat) or a high-fat diet (HF, 60% energy from fat) formulated to provide equivalent vitamin D3 intake in both groups. After 7 weeks, there was a transient increase of total 25(OH)D together with a significant decrease of plasma vitamin D3 that could be related to the induction of hepatic genes involved in 25-hydroxylation. After 11 weeks, there was no change in total 25(OH)D but a significant decrease of free 25(OH)D and plasma vitamin D3 levels. We also quantified an increase of 25(OH)D in adipose tissue that was inversely correlated to the free 25(OH)D. Interestingly, this accumulation of 25(OH)D in adipose tissue was highly correlated to the induction of Cyp2r1, which could actively participate in vitamin D3 trapping and subsequent conversion to 25(OH)D in adipose tissue. Taken together, our data strongly suggest that the enzymes involved in vitamin D metabolism, notably in adipose tissue, are transcriptionally modified under high-fat diet, thus contributing to the obesity-related reduction of free 25(OH)D.
低循环总游离 25-羟维生素 D(25(OH)D)水平表明维生素 D 状态与肥胖有关。此外,肥胖被认为在 25(OH)D 水平降低中起因果作用,并且已经提出了几种理论来解释这种关系。在这里,我们测试了肥胖症是否会破坏维生素 D 代谢的关键器官中的维生素 D 动态平衡的假设。雄性 C57BL6 小鼠在控制饮食(对照,10%能量来自脂肪)或高脂肪饮食(HF,60%能量来自脂肪)上分别喂养 7 或 11 周,以提供两组中相等的维生素 D3 摄入量。7 周后,总 25(OH)D 短暂增加,同时血浆维生素 D3 显著下降,这可能与诱导肝脏中参与 25-羟化的基因有关。11 周后,总 25(OH)D 没有变化,但游离 25(OH)D 和血浆维生素 D3 水平显著降低。我们还定量了脂肪组织中 25(OH)D 的增加,这与游离 25(OH)D 呈负相关。有趣的是,脂肪组织中 25(OH)D 的这种积累与 Cyp2r1 的诱导高度相关,Cyp2r1 可能积极参与维生素 D3 的捕获以及随后在脂肪组织中转化为 25(OH)D。总之,我们的数据强烈表明,参与维生素 D 代谢的酶,特别是在脂肪组织中,在高脂肪饮食下会发生转录修饰,从而导致与肥胖相关的游离 25(OH)D 减少。